PT  - JOURNAL ARTICLE
AU  - Ermelinda Porpiglia
AU  - Thach Mai
AU  - Peggy Kraft
AU  - Colin A. Holbrook
AU  - Antoine de Morree
AU  - Veronica D. Gonzalez
AU  - Keren Hilgendorf
AU  - Laure Fresard
AU  - Angelica Trejo
AU  - Sriram Bhimaraju
AU  - Peter K. Jackson
AU  - Wendy J. Fantl
AU  - Helen M. Blau
TI  - Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration
AID  - 10.1101/2022.04.29.489435
DP  - 2022 Jan 01
TA  - bioRxiv
PG  - 2022.04.29.489435
4099  - http://biorxiv.org/content/early/2022/04/29/2022.04.29.489435.short
4100  - http://biorxiv.org/content/early/2022/04/29/2022.04.29.489435.full
AB  - In aging, skeletal muscle strength and regenerative capacity declines due, in part, to functional impairment of muscle stem cells (MuSCs), yet the underlying mechanisms remain elusive. Here we capitalize on mass-cytometry to identify high CD47 expression as a hallmark of dysfunctional MuSCs (CD47hi) with impaired regenerative capacity that predominate with aging. The prevalent CD47hi MuSC subset suppresses the residual functional CD47lo MuSC subset through a paracrine signaling loop, leading to impaired proliferation. We uncover that elevated CD47 levels on aged MuSCs result from increased U1 snRNA expression, which disrupts alternative polyadenylation. The deficit in aged MuSC function in regeneration can be overcome either by morpholino-mediated blocking of CD47 alternative polyadenylation or antibody blockade of CD47 signaling, leading to improved regeneration in aged mice, with therapeutic implications. Our findings highlight a previously unrecognized age-dependent alteration in CD47 levels and function in MuSCs, which underlies reduced muscle repair in aging.Competing Interest StatementThe authors have declared no competing interest.